Tag: Fisher & Paykel Healthcare
Tariffs: AAH joins letter, F&P expects impact
April 3, 2025HME News Staff
WASHINGTON – AAHomecare is among 10 health care groups asking the administration to exempt medical and dental supplies, equipment and devices from tariffs in a letter to U.S. Trade Representative Jamieson Greer.
The letter was sent April 1, one day before President Donald Trump imposed numerous new tariffs, including a 10% base tariff on imports from all countries.
The letter emphasizes the potential for tariffs to raise costs and impact supply chains – ultimately...
In brief: Lobby day returns, Strive boosts diabetes biz, Heartland opens registration
March 7, 2025HME News Staff
WASHINGTON – AAHomecare will host its first full-scale, in-person Washington Legislative Conference in six years on May 12-13.
“2025 has ushered in a new administration and major leadership changes on congressional committees of jurisdiction for health care finance issues,” the association stated in a bulletin. “Our industry must take advantage of the opportunity to enlist new advocates for HME on Capitol Hill and strengthen relationships with our established...
F&P moves forward with construction plans
March 6, 2025HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel has signed a building construction contract with Dominion Constructors for the fifth building on its East Tāmaki campus in Auckland. “We are excited to add this new building to complete our East Tāmaki campus,” said Andy Niccol, COO. “This project is a purposeful investment in infrastructure to ensure we have the necessary capacity and resources in New Zealand to progress our pipeline of innovative products and therapies.” With...
In brief: Owens & Minor seeks financing, F&P ‘works through’ tariffs, docs oppose cut
February 5, 2025HME News Staff
RICHMOND, Va. – Owens & Minor is raising additional debt “while capital markets are attractive” to finance its acquisition of Rotech Healthcare, the company announced Feb. 3.
The company still expects to close on the acquisition in the first half of 2025.
“Our healthy free cash flow provides the vehicle for this proposed financing, as well as helping us achieve our deleveraging goals over the next few years,” said Edward Pesicka, president and CEO of...
F&P ‘working through complexities’ of new tariffs
February 3, 2025HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare says it does not currently anticipate a material impact from the recently announced tariffs on its net profit after tax for the 2025 financial year, but it expects its costs will likely increase for the 2026 financial year.
The company says it expects to reach its gross margin target of 65% eventually, through its long-standing continuous improvement activities across the entire business, coupled with efficient growth into existing...
F&P on masks: ‘It looks like we’re taking market share’
December 4, 2024Liz Beaulieu, Editor
AUCKLAND, New Zealand – Fisher & Paykel Healthcare’s Homecare product group helped to deliver record financial results for the first half of financial year 2025 on the back of strong performance from masks and accessories.
Revenue for the Homecare product group increased 14% and sales of masks and accessories increased 16% for the first half.
When asked by an analyst during a recent conference call whether F&P was taking share in the competitive mask category, CEO and...
Product launches: Fisher & Paykel Healthcare, Sunrise Medical, Medbill
November 15, 2024HME News Staff
Auckland, New Zealand-based Fisher & Paykel Healthcare has launched the F&P Nova Micro nasal pillows mask for the treatment of obstructive sleep apnea in the U.S. Weighing less than 1.4 ounces, the new mask features minimal, easy adjusting headgear and a soft MicroPillows cushion that nestles gently within the nostrils and inflates to conform to the patient’s nose, providing stability and freedom of movement. “The Nova Micro is another strong addition to our mask portfolio, and we are...
F&P issues half, full-year 2025 guidance
August 27, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has released guidance of revenue in the range of approximately $940 million to $950 million for the first half of its 2025 financial year, which ends Sept. 30, 2024. Full 2025 financial year guidance is expected to be in the range of approximately $1.9 billion to $2.0 billion, with full year net profit after tax to be in the range of approximately $320 million to $370 million. “The year to date has begun strongly across all products and...
F&P fills board seat
August 20, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has appointed Mark Cross to the board as a non-executive director effective Oct. 1. Cross, who currently chairs the board of Chorus, where he has been a director since 2016, replaces Scott St. John, who will retire from the board at the end of August. “Mark is a strategic thinker who understands the technology and innovation sector and brings a fresh perspective,” said St. John. “With strong business acumen and a background...
In brief: Owens & Minor earnings, DMEscripts integration, F&P launch
August 2, 2024HME News Staff
RICHMOND, Va. – Owens & Minor reported consolidated revenue of $2.7 billion for the second quarter of 2024, an increase of 4% year over year.
Of that, Patient Direct revenue was $660 million, an increase of 4%, driven by continued strong growth in diabetes and sleep supplies.
“Our Patient Direct segment performed in line with our expectations, and we expect the segment to benefit from seasonality and recent organic investments during the back half of the year,”...